These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18070216)

  • 1. Incidence of fatal adverse drug reactions: a population based study.
    Wester K; Jönsson AK; Spigset O; Druid H; Hägg S
    Br J Clin Pharmacol; 2008 Apr; 65(4):573-9. PubMed ID: 18070216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fatal adverse drug reactions in hospitalized patients.
    Pardo Cabello AJ; González Contreras LG; Manzano Gamero MV; Gómez Jiménez FJ; Puche Cañas E
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):596-602. PubMed ID: 19825322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-related deaths: an analysis of the Italian spontaneous reporting database.
    Leone R; Sottosanti L; Luisa Iorio M; Santuccio C; Conforti A; Sabatini V; Moretti U; Venegoni M
    Drug Saf; 2008; 31(8):703-13. PubMed ID: 18636789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventable drug related mortality in a Swedish population.
    Jönsson AK; Hakkarainen KM; Spigset O; Druid H; Hiselius A; Hägg S
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):211-5. PubMed ID: 19998370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal drug poisonings in a Swedish general population.
    Jönsson AK; Spigset O; Tjäderborn M; Druid H; Hägg S
    BMC Clin Pharmacol; 2009 Apr; 9():7. PubMed ID: 19397805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related deaths in a university central hospital.
    Juntti-Patinen L; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 Oct; 58(7):479-82. PubMed ID: 12389071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-related deaths in a department of internal medicine.
    Ebbesen J; Buajordet I; Erikssen J; Brørs O; Hilberg T; Svaar H; Sandvik L
    Arch Intern Med; 2001 Oct; 161(19):2317-23. PubMed ID: 11606147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series.
    Tandon VR; Khajuria V; Mahajan A; Gillani Z; Mahajan V; Chandail V
    Indian J Crit Care Med; 2014 May; 18(5):315-9. PubMed ID: 24914261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-related deaths in hospital inpatients: A retrospective cohort study.
    Montané E; Arellano AL; Sanz Y; Roca J; Farré M
    Br J Clin Pharmacol; 2018 Mar; 84(3):542-552. PubMed ID: 29148077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal adverse drug events: the paradox of drug treatment.
    Buajordet I; Ebbesen J; Erikssen J; Brørs O; Hilberg T
    J Intern Med; 2001 Oct; 250(4):327-41. PubMed ID: 11576320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden.
    Björnsson E; Jerlstad P; Bergqvist A; Olsson R
    Scand J Gastroenterol; 2005 Sep; 40(9):1095-101. PubMed ID: 16165719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data.
    Layton D; Heeley E; Shakir SA
    J Clin Pharm Ther; 2004 Apr; 29(2):171-81. PubMed ID: 15068407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study.
    Weersink RA; Taxis K; Drenth JPH; Houben E; Metselaar HJ; Borgsteede SD
    Drug Saf; 2019 Apr; 42(4):539-546. PubMed ID: 30357649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal reactions to drugs. A 10-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):451-6. PubMed ID: 452938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.